Rocket


Overview
Financials
News + Filings

 
 

Kairos Pharma, LTD. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21
Revenues0.10.2
            Revenue growth-52.5% 
Cost of goods sold0.61.9
Gross profit-0.5-1.8
            Gross margin-556.3%-961.7%
General and administrative0.51.8
EBITA-0.4-1.8
            EBITA margin-472.4%-1008.2%
Amortization of intangibles0.20.1
EBIT-0.6-1.9
            EBIT margin-656.3%-1061.7%
Pre-tax income-1.1-2.1
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income-1.1-2.1
            Net margin-1206.9%-1172.1%
 
Diluted EPS($0.10)($0.23)
Shares outstanding (diluted)10.29.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy